The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Cell Therapy CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immune Cells
1.2.3 Stem Cell
1.2.4 Viral Vector
1.2.5 Plasmid DNA
1.3 Market by Application
1.3.1 Global Gene Cell Therapy CDMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Cell Therapy CDMO Market Perspective (2019-2030)
2.2 Global Gene Cell Therapy CDMO Growth Trends by Region
2.2.1 Global Gene Cell Therapy CDMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Cell Therapy CDMO Historic Market Size by Region (2019-2024)
2.2.3 Gene Cell Therapy CDMO Forecasted Market Size by Region (2025-2030)
2.3 Gene Cell Therapy CDMO Market Dynamics
2.3.1 Gene Cell Therapy CDMO Industry Trends
2.3.2 Gene Cell Therapy CDMO Market Drivers
2.3.3 Gene Cell Therapy CDMO Market Challenges
2.3.4 Gene Cell Therapy CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Cell Therapy CDMO Players by Revenue
3.1.1 Global Top Gene Cell Therapy CDMO Players by Revenue (2019-2024)
3.1.2 Global Gene Cell Therapy CDMO Revenue Market Share by Players (2019-2024)
3.2 Global Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Cell Therapy CDMO Revenue
3.4 Global Gene Cell Therapy CDMO Market Concentration Ratio
3.4.1 Global Gene Cell Therapy CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Cell Therapy CDMO Revenue in 2023
3.5 Global Key Players of Gene Cell Therapy CDMO Head office and Area Served
3.6 Global Key Players of Gene Cell Therapy CDMO, Product and Application
3.7 Global Key Players of Gene Cell Therapy CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Cell Therapy CDMO Breakdown Data by Type
4.1 Global Gene Cell Therapy CDMO Historic Market Size by Type (2019-2024)
4.2 Global Gene Cell Therapy CDMO Forecasted Market Size by Type (2025-2030)
5 Gene Cell Therapy CDMO Breakdown Data by Application
5.1 Global Gene Cell Therapy CDMO Historic Market Size by Application (2019-2024)
5.2 Global Gene Cell Therapy CDMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Cell Therapy CDMO Market Size (2019-2030)
6.2 North America Gene Cell Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Cell Therapy CDMO Market Size by Country (2019-2024)
6.4 North America Gene Cell Therapy CDMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Cell Therapy CDMO Market Size (2019-2030)
7.2 Europe Gene Cell Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024)
7.4 Europe Gene Cell Therapy CDMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Cell Therapy CDMO Market Size (2019-2030)
8.2 Asia-Pacific Gene Cell Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Cell Therapy CDMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Cell Therapy CDMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Cell Therapy CDMO Market Size (2019-2030)
9.2 Latin America Gene Cell Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Cell Therapy CDMO Market Size by Country (2019-2024)
9.4 Latin America Gene Cell Therapy CDMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Cell Therapy CDMO Market Size (2019-2030)
10.2 Middle East & Africa Gene Cell Therapy CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Cell Therapy CDMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Cell Therapy CDMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Gene Cell Therapy CDMO Introduction
11.1.4 Catalent Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Gene Cell Therapy CDMO Introduction
11.2.4 Lonza Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Gene Cell Therapy CDMO Introduction
11.3.4 Thermo Fisher Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.3.5 Thermo Fisher Recent Development
11.4 ACG Biologics
11.4.1 ACG Biologics Company Details
11.4.2 ACG Biologics Business Overview
11.4.3 ACG Biologics Gene Cell Therapy CDMO Introduction
11.4.4 ACG Biologics Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.4.5 ACG Biologics Recent Development
11.5 Charles River
11.5.1 Charles River Company Details
11.5.2 Charles River Business Overview
11.5.3 Charles River Gene Cell Therapy CDMO Introduction
11.5.4 Charles River Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.5.5 Charles River Recent Development
11.6 Oxford Biomedica
11.6.1 Oxford Biomedica Company Details
11.6.2 Oxford Biomedica Business Overview
11.6.3 Oxford Biomedica Gene Cell Therapy CDMO Introduction
11.6.4 Oxford Biomedica Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.6.5 Oxford Biomedica Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Gene Cell Therapy CDMO Introduction
11.7.4 Novartis Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 OBiO
11.8.1 OBiO Company Details
11.8.2 OBiO Business Overview
11.8.3 OBiO Gene Cell Therapy CDMO Introduction
11.8.4 OBiO Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.8.5 OBiO Recent Development
11.9 GenScript
11.9.1 GenScript Company Details
11.9.2 GenScript Business Overview
11.9.3 GenScript Gene Cell Therapy CDMO Introduction
11.9.4 GenScript Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.9.5 GenScript Recent Development
11.10 Pharmaron
11.10.1 Pharmaron Company Details
11.10.2 Pharmaron Business Overview
11.10.3 Pharmaron Gene Cell Therapy CDMO Introduction
11.10.4 Pharmaron Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.10.5 Pharmaron Recent Development
11.11 Porton
11.11.1 Porton Company Details
11.11.2 Porton Business Overview
11.11.3 Porton Gene Cell Therapy CDMO Introduction
11.11.4 Porton Revenue in Gene Cell Therapy CDMO Business (2019-2024)
11.11.5 Porton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables

List of Tables
Table 1. Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immune Cells
Table 3. Key Players of Stem Cell
Table 4. Key Players of Viral Vector
Table 5. Key Players of Plasmid DNA
Table 6. Global Gene Cell Therapy CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Gene Cell Therapy CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Gene Cell Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Gene Cell Therapy CDMO Market Share by Region (2019-2024)
Table 10. Global Gene Cell Therapy CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Gene Cell Therapy CDMO Market Share by Region (2025-2030)
Table 12. Gene Cell Therapy CDMO Market Trends
Table 13. Gene Cell Therapy CDMO Market Drivers
Table 14. Gene Cell Therapy CDMO Market Challenges
Table 15. Gene Cell Therapy CDMO Market Restraints
Table 16. Global Gene Cell Therapy CDMO Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Gene Cell Therapy CDMO Market Share by Players (2019-2024)
Table 18. Global Top Gene Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cell Therapy CDMO as of 2023)
Table 19. Ranking of Global Top Gene Cell Therapy CDMO Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Gene Cell Therapy CDMO Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Gene Cell Therapy CDMO, Headquarters and Area Served
Table 22. Global Key Players of Gene Cell Therapy CDMO, Product and Application
Table 23. Global Key Players of Gene Cell Therapy CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gene Cell Therapy CDMO Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Gene Cell Therapy CDMO Revenue Market Share by Type (2019-2024)
Table 27. Global Gene Cell Therapy CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Gene Cell Therapy CDMO Revenue Market Share by Type (2025-2030)
Table 29. Global Gene Cell Therapy CDMO Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Gene Cell Therapy CDMO Revenue Market Share by Application (2019-2024)
Table 31. Global Gene Cell Therapy CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Gene Cell Therapy CDMO Revenue Market Share by Application (2025-2030)
Table 33. North America Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Gene Cell Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Gene Cell Therapy CDMO Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 48. Catalent Company Details
Table 49. Catalent Business Overview
Table 50. Catalent Gene Cell Therapy CDMO Product
Table 51. Catalent Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 52. Catalent Recent Development
Table 53. Lonza Company Details
Table 54. Lonza Business Overview
Table 55. Lonza Gene Cell Therapy CDMO Product
Table 56. Lonza Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 57. Lonza Recent Development
Table 58. Thermo Fisher Company Details
Table 59. Thermo Fisher Business Overview
Table 60. Thermo Fisher Gene Cell Therapy CDMO Product
Table 61. Thermo Fisher Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 62. Thermo Fisher Recent Development
Table 63. ACG Biologics Company Details
Table 64. ACG Biologics Business Overview
Table 65. ACG Biologics Gene Cell Therapy CDMO Product
Table 66. ACG Biologics Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 67. ACG Biologics Recent Development
Table 68. Charles River Company Details
Table 69. Charles River Business Overview
Table 70. Charles River Gene Cell Therapy CDMO Product
Table 71. Charles River Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 72. Charles River Recent Development
Table 73. Oxford Biomedica Company Details
Table 74. Oxford Biomedica Business Overview
Table 75. Oxford Biomedica Gene Cell Therapy CDMO Product
Table 76. Oxford Biomedica Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 77. Oxford Biomedica Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Gene Cell Therapy CDMO Product
Table 81. Novartis Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. OBiO Company Details
Table 84. OBiO Business Overview
Table 85. OBiO Gene Cell Therapy CDMO Product
Table 86. OBiO Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 87. OBiO Recent Development
Table 88. GenScript Company Details
Table 89. GenScript Business Overview
Table 90. GenScript Gene Cell Therapy CDMO Product
Table 91. GenScript Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 92. GenScript Recent Development
Table 93. Pharmaron Company Details
Table 94. Pharmaron Business Overview
Table 95. Pharmaron Gene Cell Therapy CDMO Product
Table 96. Pharmaron Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 97. Pharmaron Recent Development
Table 98. Porton Company Details
Table 99. Porton Business Overview
Table 100. Porton Gene Cell Therapy CDMO Product
Table 101. Porton Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 102. Porton Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report


List of Figures
Figure 1. Gene Cell Therapy CDMO Picture
Figure 2. Global Gene Cell Therapy CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gene Cell Therapy CDMO Market Share by Type: 2023 VS 2030
Figure 4. Immune Cells Features
Figure 5. Stem Cell Features
Figure 6. Viral Vector Features
Figure 7. Plasmid DNA Features
Figure 8. Global Gene Cell Therapy CDMO Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Gene Cell Therapy CDMO Market Share by Application: 2023 VS 2030
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research and Academic Institutions Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Gene Cell Therapy CDMO Report Years Considered
Figure 15. Global Gene Cell Therapy CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Gene Cell Therapy CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Gene Cell Therapy CDMO Market Share by Region: 2023 VS 2030
Figure 18. Global Gene Cell Therapy CDMO Market Share by Players in 2023
Figure 19. Global Top Gene Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cell Therapy CDMO as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Gene Cell Therapy CDMO Revenue in 2023
Figure 21. North America Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 23. United States Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 27. Germany Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Gene Cell Therapy CDMO Market Share by Region (2019-2030)
Figure 35. China Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 43. Mexico Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 47. Turkey Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Catalent Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 51. Lonza Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 52. Thermo Fisher Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 53. ACG Biologics Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 54. Charles River Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 55. Oxford Biomedica Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 57. OBiO Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 58. GenScript Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 59. Pharmaron Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 60. Porton Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed